MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Conceptus swaps out $50 million in senior notes | Funding Roundup

Conceptus swaps out $50 million in senior notes | Funding Roundup

By

Conceptus Inc. logo

Conceptus (NSDQ:CPTS) swapped out $50 million worth of 2.25% senior notes due 2027 from a select group of holders, exchanging them for 5% notes due 2031, regulatory filings show.

The principal amount on the new notes was an even swap for the originals, which was determined in individual negotiations between Conceptus and the holders.

The subscription agreement follows the sudden swap of former CEO Mark Sieczkarek and promotion of Keith Grossman to president upon lowering of 2012 guidance for the Mountain View, Calif.-based contraceptive devices maker.

Early in December Conceptus also announced that it canceled its $50 million revolving credit line with Wells Fargo Bank citing uncertainty about being able to meet "certain financial covenants."

Later in the month the company revealed that it entered into an Indenture with Wells Fargo as a trustee in connection with the note exchange.

The new notes are convertible into cash, shares of common stock or a combination of the two, according to filings.

Funding

Here’s a roundup of other dealflow and investment news:

Clear Catheter Systems closes first round of funding with $4 million

Clear Catheter Systems Inc., developer of medical devices used in post-surgical recovery, closed its first institutional round of financing. The $4 million round was co-led by Aphelion Capital and California Technology Ventures.
Read more

Velomedix nears close of $10.7M round
Menlo Park, Calif.-based therapeutic hypothermia device maker Velomedix Inc. raised $9.3 million of a hoped-for $10.7 funding round.
Read more

Lucid closes $5.3 million funding round

Lucid Inc. (OTCBB: LCDCU) closed its public offering of 1,388,000 units, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock. Net proceeds were approximately $5.30 million, after deducting the underwriting discount and corporate finance fee, but before taking into account estimated offering expenses. Read more

iCad touts $15 million debt facility
iCad Inc. (NSDQ: ICAD), provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, entered into a 5 year, $15 million debt facility agreement with Deerfield Management Company LP. Read more

ProUroCare borrows $80,000
ProUroCare Medical Inc. borrowed $40,000 from each of Larry Musich and Alisa Piazza pursuant to promissory notes. The unsecured promissory notes bear interest at 10% per annum and mature on March 22, 2012. In addition, pursuant to the terms of the Piazza note, the company issued to the lender a five-year warrant to purchase 17,500 shares of the company’s common stock at $1.30 per share.
Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]
  • ResMed names Lucile Blaise as new Sleep & Respiratory Care leader
    Lucile Blaise will be the new president of ResMed’s Sleep & Respiratory Care business starting July 1, ResMed (NYSE: RMD) said today. She replaces Jim Hollingshead, who became president and CEO of Insulet (Nasdaq:PODD) on June 1. ResMed President and COO Rob Douglas is serving as interim president of the Sleep & Respiratory Care during… […]

Leave a Reply